Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ortataxel in taxane-resistant metastatic breast cancer
NCT00044525Phase 2Completed
- Sponsor
- Bayer
- Start
- Apr 2002
- Primary completion
- Feb 2004
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of ortataxel in breast cancer, sponsored by Bayer. Started Apr 2002; status: completed.
02
Drugs
ortataxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00044525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044525.